Haemonetics Interventional Technologies

Haemonetics Interventional Technologies is a division of Haemonetics, a global medical technology company established in 1971. This division focuses on advanced interventional medical technologies aimed at improving procedural outcomes and patient care in hospital environments. The company offers a range of products, including vascular closure systems like the VASCADE and VASCADE MVP, which facilitate rapid hemostasis after procedures. They also provide sensor-guided technologies, such as the SavvyWire® Pre-Shaped Pressure Guidewire, for diagnosing and treating coronary artery disease. Additionally, Haemonetics markets an FDA-cleared temperature regulation device for esophageal protection during cardiac ablation procedures, enhancing patient safety. Their proprietary fiber optic sensing technology is designed for integration into various medical devices, ensuring precise measurement of critical parameters. Haemonetics Interventional Technologies serves hospitals and healthcare providers involved in interventional cardiology and related fields, supporting clinicians in delivering high-quality care and improving patient outcomes.

• Employees 240
• Founded 2003